Post Reply
1-20 of 244
anything with good news, I will stay aside
Congrats. Good move. I stay sideline.
gregtan123 ( Date: 30-Jul-2020 12:25) Posted:
| Just short at the top 0.028/0/0.029 i never naked short cause i got shares but i soold thenbuy back. free money. BB loser one |
|
Just short at the top 0.028/0/0.029 i never naked short cause i got shares but i soold thenbuy back. free money. BB loser one
bb dump we collect
Haha pump and dump part 100 liao. this BB everyday ownself pump for retails to shoort
toyy65 ( Date: 30-Jul-2020 08:55) Posted:
| it is going to run............... |
|
it is going to run...............
Going into medical device business too.......
bro today close so badly 2.2, tmr can run ah? thursday last trading day lei, im doubtful.
Shifu8888 ( Date: 29-Jul-2020 19:11) Posted:
Not sure.... but tmr sure run. Got profit take. This is a China company.
gregtan123 ( Date: 29-Jul-2020 18:16) Posted:
| so bro this stock run far far? entry 2.3 can exit above 3? i only have 75,000 shares haha |
|
|
|
Not sure.... but tmr sure run. Got profit take. This is a China company.
gregtan123 ( Date: 29-Jul-2020 18:16) Posted:
so bro this stock run far far? entry 2.3 can exit above 3? i only have 75,000 shares haha.
Shifu8888 ( Date: 29-Jul-2020 18:11) Posted:
Bro I think I told you before the news they will be venturing into thermometers and thermoscan and stuff.
Anyway, beware this is the third time I think they are diversifying. Everyone jump into medical play |
|
|
|
Seriously??
shk363 ( Date: 29-Jul-2020 18:44) Posted:
|
no 50 no sell
so bro this stock run far far? entry 2.3 can exit above 3? i only have 75,000 shares haha.
Shifu8888 ( Date: 29-Jul-2020 18:11) Posted:
Bro I think I told you before the news they will be venturing into thermometers and thermoscan and stuff.
Anyway, beware this is the third time I think they are diversifying. Everyone jump into medical play.
gregtan123 ( Date: 29-Jul-2020 18:03) Posted:
this explains the DMG buying like mad to push to 3.1 that day! BBs loaded then let it come back down. but Medical Play!! Diversification to NEW BIZ
Medical Device Business Subject to approval of shareholders of the Company (the &ldquo Shareholders&rdquo ) being obtained at an extraordinary general meeting (&ldquo EGM&rdquo ) to be convened, the Group proposes to diversify into the new business described below, as and when the appropriate opportunities arise: (a) To research, develop and design hardware and software of medical devices and other related products which include but not limited to homecare products, respiratory products, rehabilitation products, hospital instruments, the matching reagents, and other accessories and materials used for the production of medical devices (the &ldquo Products&rdquo ) (b) To engage in the trading, manufacturing, distributing and/or marketing of the Products and (c) To provide consultancy service in relation to design hardware and software of the Products and other related services (the &ldquo Services&rdquo ), collectively the &ldquo Medical Device Business&rdquo . The Group also proposes, as part of the Medical Device Business, to invest or acquire from time to time any interest, including assets, investments or shares in companies and/or entities in line with the Medical Device Business.
Rationale for the Proposed Diversification (a) Enhance Shareholders&rsquo value The Proposed Diversification will enable the Group to participate in a new market, offering new business opportunities which would potentially provide additional and recurrent revenue streams and assist in continual growth of the Group, thereby enhancing the Group&rsquo s financial position and Shareholders&rsquo value. (b) Complementary to existing business The technologies of IMD and plastic components can be applied in the industry of the manufacturing of the Products. As such, the Group endeavours to potentially leverage on the Group&rsquo s current experience and knowledge in the related field which would provide a competitive advantage to the Group as a new entrant and synergy to the Group&rsquo s existing operations. (c) Reducing reliance of the Existing Business With the new business opportunities that the Medical Device Business provides, the Group would be able to reduce its reliance on the Existing Business, which remains challenging. The Proposed Diversification is expected to mitigate volatility in the Existing Business and improve the Group&rsquo s long-term prospects as a whole. (d) Potential in the Medical Device Business Medical devices are essential for safe and effective prevention, diagnosis, treatment and rehabilitation of illnesses and diseases. Overall industry revenue of medical devices in PRC is estimated to exceed RMB 700 billion in 2020, recording a year-on-year increase of 17.9%. From 2013 to 2019, the annual growth rate of the said overall industry revenue had been above 15%.1 The Group has assessed the potential of the medical device market and is optimistic that the increase in healthcare awareness is expected to drive growth in the medical device industry worldwide in the long-term. The Proposed Diversification would allow the Group to participate in the growth prospects of the medical device industry and to maximise returns to shareholders in the long-term. |
|
|
|
Bro I think I told you before the news they will be venturing into thermometers and thermoscan and stuff.
Anyway, beware this is the third time I think they are diversifying. Everyone jump into medical play.
gregtan123 ( Date: 29-Jul-2020 18:03) Posted:
this explains the DMG buying like mad to push to 3.1 that day! BBs loaded then let it come back down. but Medical Play!! Diversification to NEW BIZ
Medical Device Business Subject to approval of shareholders of the Company (the &ldquo Shareholders&rdquo ) being obtained at an extraordinary general meeting (&ldquo EGM&rdquo ) to be convened, the Group proposes to diversify into the new business described below, as and when the appropriate opportunities arise: (a) To research, develop and design hardware and software of medical devices and other related products which include but not limited to homecare products, respiratory products, rehabilitation products, hospital instruments, the matching reagents, and other accessories and materials used for the production of medical devices (the &ldquo Products&rdquo ) (b) To engage in the trading, manufacturing, distributing and/or marketing of the Products and (c) To provide consultancy service in relation to design hardware and software of the Products and other related services (the &ldquo Services&rdquo ), collectively the &ldquo Medical Device Business&rdquo . The Group also proposes, as part of the Medical Device Business, to invest or acquire from time to time any interest, including assets, investments or shares in companies and/or entities in line with the Medical Device Business.
Rationale for the Proposed Diversification (a) Enhance Shareholders&rsquo value The Proposed Diversification will enable the Group to participate in a new market, offering new business opportunities which would potentially provide additional and recurrent revenue streams and assist in continual growth of the Group, thereby enhancing the Group&rsquo s financial position and Shareholders&rsquo value. (b) Complementary to existing business The technologies of IMD and plastic components can be applied in the industry of the manufacturing of the Products. As such, the Group endeavours to potentially leverage on the Group&rsquo s current experience and knowledge in the related field which would provide a competitive advantage to the Group as a new entrant and synergy to the Group&rsquo s existing operations. (c) Reducing reliance of the Existing Business With the new business opportunities that the Medical Device Business provides, the Group would be able to reduce its reliance on the Existing Business, which remains challenging. The Proposed Diversification is expected to mitigate volatility in the Existing Business and improve the Group&rsquo s long-term prospects as a whole. (d) Potential in the Medical Device Business Medical devices are essential for safe and effective prevention, diagnosis, treatment and rehabilitation of illnesses and diseases. Overall industry revenue of medical devices in PRC is estimated to exceed RMB 700 billion in 2020, recording a year-on-year increase of 17.9%. From 2013 to 2019, the annual growth rate of the said overall industry revenue had been above 15%.1 The Group has assessed the potential of the medical device market and is optimistic that the increase in healthcare awareness is expected to drive growth in the medical device industry worldwide in the long-term. The Proposed Diversification would allow the Group to participate in the growth prospects of the medical device industry and to maximise returns to shareholders in the long-term. |
|
this explains the DMG buying like mad to push to 3.1 that day! BBs loaded then let it come back down. but Medical Play!! Diversification to NEW BIZ
Medical Device Business Subject to approval of shareholders of the Company (the &ldquo Shareholders&rdquo ) being obtained at an extraordinary general meeting (&ldquo EGM&rdquo ) to be convened, the Group proposes to diversify into the new business described below, as and when the appropriate opportunities arise: (a) To research, develop and design hardware and software of medical devices and other related products which include but not limited to homecare products, respiratory products, rehabilitation products, hospital instruments, the matching reagents, and other accessories and materials used for the production of medical devices (the &ldquo Products&rdquo ) (b) To engage in the trading, manufacturing, distributing and/or marketing of the Products and (c) To provide consultancy service in relation to design hardware and software of the Products and other related services (the &ldquo Services&rdquo ), collectively the &ldquo Medical Device Business&rdquo . The Group also proposes, as part of the Medical Device Business, to invest or acquire from time to time any interest, including assets, investments or shares in companies and/or entities in line with the Medical Device Business.
Rationale for the Proposed Diversification (a) Enhance Shareholders&rsquo value The Proposed Diversification will enable the Group to participate in a new market, offering new business opportunities which would potentially provide additional and recurrent revenue streams and assist in continual growth of the Group, thereby enhancing the Group&rsquo s financial position and Shareholders&rsquo value. (b) Complementary to existing business The technologies of IMD and plastic components can be applied in the industry of the manufacturing of the Products. As such, the Group endeavours to potentially leverage on the Group&rsquo s current experience and knowledge in the related field which would provide a competitive advantage to the Group as a new entrant and synergy to the Group&rsquo s existing operations. (c) Reducing reliance of the Existing Business With the new business opportunities that the Medical Device Business provides, the Group would be able to reduce its reliance on the Existing Business, which remains challenging. The Proposed Diversification is expected to mitigate volatility in the Existing Business and improve the Group&rsquo s long-term prospects as a whole. (d) Potential in the Medical Device Business Medical devices are essential for safe and effective prevention, diagnosis, treatment and rehabilitation of illnesses and diseases. Overall industry revenue of medical devices in PRC is estimated to exceed RMB 700 billion in 2020, recording a year-on-year increase of 17.9%. From 2013 to 2019, the annual growth rate of the said overall industry revenue had been above 15%.1 The Group has assessed the potential of the medical device market and is optimistic that the increase in healthcare awareness is expected to drive growth in the medical device industry worldwide in the long-term. The Proposed Diversification would allow the Group to participate in the growth prospects of the medical device industry and to maximise returns to shareholders in the long-term.
i tot Kunda iss 1-day wonder/scam? i was thinking tomorrow say 2.6 or 2.5 just open short sell 500,000 first. end of the day pick up 2.3
Bull_Runner ( Date: 24-Jul-2020 00:12) Posted:
I think the " low" will come at Tues/Wed..
Wait for T+2 contra players to sell first and see how..
gregtan123 ( Date: 23-Jul-2020 18:49) Posted:
Average Short Price: 0.02749. Sold: 2.7 (bought 2.82 ave), lose 109.99. Short 2.8, cover 2.6 Make 100. Tomorrow short back to 2.2?
$ ChinaKundaTech 1140000 SGD 31340
|
|
|
|
I think the " low" will come at Tues/Wed..
Wait for T+2 contra players to sell first and see how..
gregtan123 ( Date: 23-Jul-2020 18:49) Posted:
Average Short Price: 0.02749. Sold: 2.7 (bought 2.82 ave), lose 109.99. Short 2.8, cover 2.6 Make 100. Tomorrow short back to 2.2?
$ ChinaKundaTech 1140000 SGD 31340
|
|
Average Short Price: 0.02749. Sold: 2.7 (bought 2.82 ave), lose 109.99. Short 2.8, cover 2.6 Make 100. Tomorrow short back to 2.2?
$ ChinaKundaTech 1140000 SGD 31340
can close 2.4? shorted at 2.7, come on lei.
Bro, this one I outed Liao. I will buy unless this is sub 20. Any price now is con job.
gregtan123 ( Date: 23-Jul-2020 13:34) Posted:
Bro BB tthis time let retails all out at 3 cents? then trap itself? Can continue sell down not?
Shifu8888 ( Date: 16-Jul-2020 10:47) Posted:
| If you study this bugger movement, every time it fry up, it will never touch the previous high. Why? Bb will not want people stuck to get out. This time round, true enough, it will not touch 3. It kiss 27 and then fall. Next round, it will fizzle to sub 20 and till fry again and kiss 23 max. This seems another bunch of china crooks. Anyway, I have no position now. I will wait at 17/1 |
|
|
|
Bro BB tthis time let retails all out at 3 cents? then trap itself? Can continue sell down not?
Shifu8888 ( Date: 16-Jul-2020 10:47) Posted:
If you study this bugger movement, every time it fry up, it will never touch the previous high. Why? Bb will not want people stuck to get out. This time round, true enough, it will not touch 3. It kiss 27 and then fall. Next round, it will fizzle to sub 20 and till fry again and kiss 23 max. This seems another bunch of china crooks. Anyway, I have no position now. I will wait at 17/18
gregtan123 ( Date: 16-Jul-2020 10:36) Posted:
China Economy Returned to Growth Last Quarter as Virus Eased: Kunda is based in Beijing (heart of recovery)
The Chinese economy returned to growth in the second quarter, marking an important milestone in the global struggle to recover from the coronavirus pandemic.
Gross domestic product expanded 3.2% in the three months to June from a year ago, reversing a 6.8% decline in the first quarter and BEATING the median forecast of 2.4%. In the first half however, output is still down 1.6% on the same period in 2019.
|
|
|
|
